ADCT
ADC Therapeutics SA
Company overview
- Market capitalization
- $160.86M
- Employees
- 188
- Latest publication
- 2026-09-29
About ADC Therapeutics SA
ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration, conditional approval from the European Commission, and conditional approval from the China National Medical Products Administration for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy. The company is also seeking to continue expanding ZYNLONTA into international markets and into earlier lines of DLBCL and indolent lymphomas, including follicular lymphoma (FL) and marginal zone lymphoma (MZL) as a single agent and in combination through its LOTIS-5 confirmatory Phase 3 clinical trial and LOTIS-7 Phase 1b clinical trial, as well as through investigator-initiated trials (IITs). In addition, it is investigating a CD-22 targeted compound' and ADCT-602 that is in a Phase 1/2 IIT in refractory B-cell acute lymphoblastic leukemia. Further, the company's pre-clinical stage pipeline includes a portfolio of next generation investigational ADCs targeting Claudin-6, NaPi2b, PSMA, NaPi2b, and ASCT2. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 19,248,000USD | 20,851,000USD | 23,058,000USD | 16,427,000USD | 18,839,000USD | 23,033,000USD | 16,910,000USD | 18,464,000USD |
| Cost Of Revenue | 2,349,000USD | 3,615,000USD | 1,699,000USD | 1,202,000USD | 836,000USD | 2,061,000USD | 1,371,000USD | 851,000USD |
| Gross Profit | 16,899,000USD | 17,236,000USD | 21,359,000USD | 15,225,000USD | 18,003,000USD | 20,972,000USD | 15,539,000USD | 17,613,000USD |
| Research Development | 17,366,000USD | 19,877,000USD | 18,184,000USD | 26,803,000USD | 30,090,000USD | 28,928,000USD | 27,101,000USD | 32,502,000USD |
| Selling General Administrative | 9,701,000USD | 9,896,000USD | 15,588,000USD | 14,015,000USD | 14,964,000USD | 9,955,000USD | 15,150,000USD | 15,619,000USD |
| Selling And Marketing Expenses | 12,572,000USD | 12,708,000USD | 5,854,000USD | 4,999,000USD | 4,005,000USD | 10,553,000USD | 5,724,000USD | 5,056,000USD |
| General And Administrative Expenses | 9,701,000USD | — | — | — | — | — | — | — |
| Other Operating Expenses | 2,674,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 42,313,000USD | 42,481,000USD | 39,482,000USD | 46,194,000USD | 62,150,000USD | 49,436,000USD | 47,975,000USD | 53,177,000USD |
| Operating Income | -25,414,000USD | -25,245,000USD | -18,123,000USD | -30,969,000USD | -44,147,000USD | -28,464,000USD | -32,436,000USD | -35,564,000USD |
| Total Other Income Expense Net | 8,849,000USD | -7,723,000USD | 11,310,000USD | -9,997,000USD | -11,245,000USD | -9,973,000USD | 1,388,000USD | -8,315,000USD |
| Interest Income | 1,819,000USD | 1,994,000USD | 2,352,000USD | 2,470,000USD | 1,934,000USD | 2,054,000USD | 2,633,000USD | 3,438,000USD |
| Interest Expense | 13,508,000USD | 12,349,000USD | 13,014,000USD | 13,392,000USD | 12,997,000USD | 12,230,000USD | 11,919,000USD | 13,117,000USD |
| Income Before Tax | -16,565,000USD | -32,968,000USD | -6,813,000USD | -40,966,000USD | -55,392,000USD | -38,437,000USD | -31,048,000USD | -43,879,000USD |
| Income Tax Expense | 0USD | — | -404,000USD | — | 1,254,000USD | 165,000USD | -321,000USD | 90,000USD |
| Net Income | -16,565,000USD | -32,968,000USD | -6,409,000USD | -40,966,000USD | -56,646,000USD | -38,602,000USD | -30,727,000USD | -43,969,000USD |
| Net Interest Income | — | -10,355,000USD | -10,662,000USD | -10,922,000USD | -11,063,000USD | -10,176,000USD | -9,286,000USD | -9,679,000USD |
| Tax Provision | — | 0USD | -404,000USD | 0USD | 1,254,000USD | 165,000USD | -321,000USD | 90,000USD |
| Net Income From Continuing Ops | — | -32,968,000USD | -6,409,000USD | -40,966,000USD | -56,646,000USD | -38,602,000USD | -30,727,000USD | -43,969,000USD |
| Ebit | — | -25,245,000USD | 6,201,000USD | -27,574,000USD | -42,395,000USD | -26,488,000USD | -19,625,000USD | -30,502,000USD |
| Ebitda | — | -25,132,000USD | 6,314,000USD | -27,452,000USD | -41,555,000USD | -25,687,000USD | -18,832,000USD | -29,700,000USD |
| Depreciation And Amortization | — | 113,000USD | 113,000USD | 122,000USD | 840,000USD | 801,000USD | 793,000USD | 802,000USD |
| Reconciled Depreciation | — | 114,000USD | 113,000USD | 122,000USD | 840,000USD | 801,000USD | 793,000USD | 802,000USD |
| Unclassified Operating Expenses | — | — | — | — | 13,091,000USD | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 81,357,000USD | 70,837,000USD | 69,558,000USD | 209,908,000USD | 33,917,000USD | 0USD | 2,340,000USD | 1,140,000USD |
| Cost Of Revenue | 7,674,000USD | 5,949,000USD | 2,529,000USD | 3,301,000USD | 1,393,000USD | 141,816,000USD | 107,537,000USD | 118,086,000USD |
| Gross Profit | 73,683,000USD | 64,888,000USD | 67,029,000USD | 206,607,000USD | 32,524,000USD | -141,816,000USD | 2,340,000USD | -116,946,000USD |
| Research Development | 104,005,000USD | 109,633,000USD | 127,127,000USD | 186,457,000USD | 158,002,000USD | 142,032,000USD | 107,537,000USD | 118,313,000USD |
| Selling General Administrative | 36,559,000USD | 64,467,000USD | 72,882,000USD | 107,742,000USD | 71,462,000USD | 55,130,000USD | 14,202,000USD | 8,602,000USD |
| Unclassified Operating Expenses | 41,498,000USD | — | — | — | — | -119,715,000USD | — | — |
| Total Operating Expenses | 182,062,000USD | 195,542,000USD | 233,015,000USD | 329,951,000USD | 294,244,000USD | 77,447,000USD | 121,739,000USD | 127,081,000USD |
| Operating Income | -108,379,000USD | -130,654,000USD | -165,986,000USD | -123,344,000USD | -261,720,000USD | -219,263,000USD | -119,399,000USD | -125,941,000USD |
| Interest Income | 8,810,000USD | 12,272,000USD | 6,623,000USD | 17,970,000USD | 66,000USD | 832,000USD | 2,253,000USD | 2,856,000USD |
| Interest Expense | 51,633,000USD | 50,211,000USD | 46,325,000USD | 36,731,000USD | 18,340,000USD | 4,926,000USD | 156,000USD | 3,282,000USD |
| Net Interest Income | -42,823,000USD | -37,939,000USD | -39,577,000USD | -18,954,000USD | -18,274,000USD | -4,094,000USD | 2,097,000USD | 2,856,000USD |
| Income Before Tax | -142,780,000USD | -157,680,000USD | -200,947,000USD | -156,901,000USD | -251,505,000USD | -245,963,000USD | -115,902,000USD | -122,872,000USD |
| Income Tax Expense | -157,000USD | 166,000USD | 39,106,000USD | 227,000USD | -21,479,000USD | 327,000USD | 582,000USD | 224,000USD |
| Tax Provision | 1,015,000USD | 166,000USD | -2,991,000USD | 1,139,000USD | -21,479,000USD | 327,000USD | 582,000USD | 224,000USD |
| Net Income | -142,623,000USD | -157,846,000USD | -240,053,000USD | -157,128,000USD | -230,026,000USD | -246,290,000USD | -116,484,000USD | -123,096,000USD |
| Net Income From Continuing Ops | -142,623,000USD | -157,846,000USD | -178,507,000USD | -155,800,000USD | -230,026,000USD | -246,290,000USD | -116,484,000USD | -123,096,000USD |
| Ebit | -108,379,000USD | -105,925,000USD | -149,094,000USD | -110,086,000USD | -233,165,000USD | -219,047,000USD | -115,746,000USD | -122,872,000USD |
| Ebitda | -106,503,000USD | -102,649,000USD | -145,827,000USD | -107,698,000USD | -230,535,000USD | -218,226,000USD | -114,100,000USD | -122,359,000USD |
| Depreciation And Amortization | 1,876,000USD | 3,276,000USD | 3,267,000USD | 2,388,000USD | 2,630,000USD | 821,000USD | 1,646,000USD | 513,000USD |
| Reconciled Depreciation | 1,876,000USD | 3,276,000USD | 2,832,000USD | 2,328,000USD | 2,630,000USD | 2,188,000USD | 1,646,000USD | 740,000USD |
| Total Other Income Expense Net | -34,401,000USD | -27,026,000USD | -34,961,000USD | -33,557,000USD | 10,215,000USD | -26,700,000USD | 3,497,000USD | 3,069,000USD |
| Selling And Marketing Expenses | — | 21,442,000USD | 33,006,000USD | 35,752,000USD | 64,780,000USD | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | -155,800,000USD | -230,026,000USD | -246,290,000USD | -116,484,000USD | -123,096,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 279,379,000USD | 291,496,000USD | 323,150,000USD | 289,758,000USD | 321,561,000USD | 272,539,000USD | 321,980,000USD | 349,079,000USD |
| Cash And Equivalents | 219,107,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 261,707,000USD | 276,768,000USD | 306,335,000USD | 287,149,000USD | 318,755,000USD | 257,988,999USD | 307,390,000USD | 333,005,000USD |
| Other Current Assets | 4,253,000USD | 9,939,000USD | 11,696,000USD | 11,451,000USD | 10,248,000USD | 14,078,999USD | 17,820,000USD | 18,631,000USD |
| Other Non Current Assets | 1,243,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 507,584,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 86,332,000USD | 67,628,000USD | 70,163,000USD | 62,044,000USD | 64,600,000USD | 57,794,000USD | 80,469,000USD | 67,679,000USD |
| Other Current Liabilities | 67,391,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 6,167,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -228,205,000USD | -216,377,000USD | -185,834,000USD | -238,183,000USD | -199,184,000USD | -238,223,000USD | -202,642,000USD | -171,946,000USD |
| Total Equity Including Noncontrolling Interest | -228,205,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 6,180,000USD | 4,635,000USD | 3,000,000USD | — | — | — | — | — |
| Net Receivables | 28,035,000USD | 31,045,000USD | 29,117,000USD | 22,918,000USD | 26,184,000USD | 31,762,000USD | 20,316,000USD | 24,030,000USD |
| Inventory | 4,932,000USD | 4,776,000USD | 4,184,000USD | 18,042,000USD | 17,763,000USD | 17,447,000USD | 18,387,000USD | 16,072,000USD |
| Property Plant Equipment Net | 1,101,000USD | 1,200,000USD | 1,297,000USD | 1,393,000USD | 1,489,000USD | 13,387,000USD | 13,429,000USD | 14,909,000USD |
| Accounts Payable | 12,761,000USD | 5,295,000USD | 9,175,000USD | 8,119,000USD | 9,616,000USD | 15,592,000USD | 18,029,000USD | 14,372,000USD |
| Common Stock | 11,254,000USD | 11,227,000USD | 11,080,000USD | 9,763,000USD | 9,753,000USD | 8,439,000USD | 8,425,000USD | 8,233,000USD |
| Retained Earnings | -1,685,474,000USD | -1,668,909,000USD | -1,635,941,000USD | -1,629,532,000USD | -1,588,566,000USD | -1,531,920,000USD | -1,493,318,000USD | -1,462,591,000USD |
| Accumulated Other Comprehensive Income | -814,000USD | -802,000USD | -517,000USD | -702,000USD | -388,000USD | -1,091,999USD | -1,421,000USD | 203,000USD |
| Total Liab | — | 507,873,000USD | 508,984,000USD | 527,941,000USD | 520,745,000USD | 510,762,000USD | 524,622,000USD | 521,025,000USD |
| Other Current Liab | — | 57,698,000USD | 57,988,000USD | 52,992,000USD | 53,192,000USD | 40,834,000USD | 61,069,000USD | 51,828,000USD |
| Capital Stock | — | 11,227,000USD | 11,080,000USD | 9,763,000USD | 9,753,000USD | 8,439,000USD | 8,425,000USD | 8,233,000USD |
| Cash | — | 231,008,000USD | 261,338,000USD | 234,738,000USD | 264,560,000USD | 194,701,000USD | 250,867,000USD | 274,272,000USD |
| Cash And Short Term Investments | — | 231,008,000USD | 261,338,000USD | 234,738,000USD | 264,560,000USD | 194,701,000USD | 250,867,000USD | 274,272,000USD |
| Net Debt | — | 190,347,000USD | 177,673,000USD | -117,472,000USD | -147,037,000USD | 255,189,000USD | -127,869,000USD | -149,721,000USD |
| Short Term Debt | — | 4,635,000USD | 3,000,000USD | 933,000USD | 1,792,000USD | 1,368,000USD | 1,371,000USD | 1,479,000USD |
| Short Long Term Debt Total | — | 421,355,000USD | 439,011,000USD | 117,266,000USD | 117,523,000USD | 449,890,000USD | 122,998,000USD | 124,551,000USD |
| Long Term Debt | — | 111,042,000USD | 112,452,000USD | 115,206,000USD | 114,473,000USD | 113,823,000USD | 113,632,000USD | 114,189,000USD |
| Property Plant Equipment Gross | — | 1,200,000USD | 2,678,000USD | 7,728,000USD | 7,924,000USD | 19,184,000USD | 18,749,000USD | 20,142,000USD |
| Common Stock Shares Outstanding | — | 154,142,347shares | 150,301,213shares | 136,446,534shares | 113,743,358shares | 107,202,374shares | 105,396,677shares | 104,824,877shares |
| Non Current Assets Total | — | 14,728,000USD | 16,815,000USD | 2,609,000USD | 2,806,000USD | 14,550,001USD | 14,590,000USD | 16,074,000USD |
| Non Current Liabilities Total | — | 440,245,000USD | 438,821,000USD | 465,897,000USD | 456,145,000USD | 452,968,000USD | 444,153,000USD | 453,346,000USD |
| Non Current Liabilities Other | — | 4,998,000USD | 2,810,000USD | 9,394,000USD | 7,170,000USD | 4,446,000USD | 2,433,000USD | 7,649,000USD |
| Non Currrent Assets Other | — | 13,528,000USD | 15,518,000USD | 1,216,000USD | 1,317,000USD | 1,163,001USD | 1,161,000USD | 1,165,000USD |
| Net Working Capital | — | 209,140,000USD | 236,172,000USD | 225,105,000USD | 254,155,000USD | 200,195,000USD | 226,921,000USD | 265,326,000USD |
| Unclassified Current Liabilities | — | -4,635,000USD | -3,000,000USD | — | — | — | — | — |
| Unclassified Non Current Liabilities | — | 324,205,000USD | 323,559,000USD | 341,297,000USD | 334,502,000USD | 334,699,000USD | 328,088,000USD | 331,508,000USD |
| Unclassified Equity | — | 1,430,880,000USD | 1,428,464,000USD | 1,372,525,000USD | 1,370,264,000USD | 1,277,910,999USD | 1,275,247,000USD | 1,273,976,000USD |
| Long Term Investments | — | — | — | — | — | — | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 323,150,000USD | 321,980,000USD | 354,782,000USD | 490,859,000USD | 617,972,000USD | 513,692,000USD | 137,682,000USD | 150,558,000USD |
| Other Current Assets | 11,696,000USD | 17,820,000USD | 16,334,000USD | 23,495,000USD | 15,350,000USD | 8,564,999USD | 4,215,000USD | 1,384,000USD |
| Total Liab | 508,984,000USD | 524,622,000USD | 503,031,000USD | 411,408,000USD | 451,884,000USD | 178,187,000USD | 26,526,000USD | 24,315,000USD |
| Total Stockholder Equity | -185,834,000USD | -202,642,000USD | -148,249,000USD | 79,451,000USD | 166,088,000USD | 335,505,000USD | 111,156,000USD | 126,243,000USD |
| Other Current Liab | 57,988,000USD | 61,069,000USD | 50,634,000USD | 56,017,000USD | 50,497,000USD | 35,654,000USD | 15,430,000USD | 13,635,000USD |
| Common Stock | 11,080,000USD | 8,425,000USD | 7,312,000USD | 7,312,000USD | 6,445,000USD | 6,314,000USD | 4,361,000USD | 401,000USD |
| Capital Stock | 11,080,000USD | 8,425,000USD | 7,312,000USD | 7,312,000USD | 6,445,000USD | 6,314,000USD | 4,361,000USD | 401,000USD |
| Retained Earnings | -1,635,941,000USD | -1,493,318,000USD | -1,335,472,000USD | -1,095,419,000USD | -924,885,000USD | -694,859,000USD | -448,569,000USD | -332,085,000USD |
| Cash | 261,338,000USD | 250,867,000USD | 278,598,000USD | 326,441,000USD | 466,544,000USD | 439,195,000USD | 115,551,000USD | 138,807,000USD |
| Cash And Short Term Investments | 261,338,000USD | 250,867,000USD | 278,598,000USD | 326,441,000USD | 466,544,000USD | 439,195,000USD | 115,551,000USD | 138,807,000USD |
| Total Current Assets | 306,335,000USD | 307,390,000USD | 336,291,000USD | 434,980,000USD | 525,182,000USD | 450,450,000USD | 122,606,000USD | 142,080,000USD |
| Total Current Liabilities | 70,163,000USD | 80,469,000USD | 67,670,000USD | 81,939,000USD | 73,935,000USD | 40,436,000USD | 19,943,000USD | 22,354,000USD |
| Net Debt | 177,673,000USD | -127,869,000USD | -154,221,000USD | -196,592,000USD | -326,846,000USD | -324,114,000USD | -110,520,000USD | -138,807,000USD |
| Short Term Debt | 3,000,000USD | 1,371,000USD | 1,467,000USD | 13,571,000USD | 7,604,000USD | 4,633,000USD | 1,132,000USD | — |
| Short Long Term Debt | 3,000,000USD | — | — | 12,474,000USD | 6,575,000USD | 3,631,000USD | — | — |
| Short Long Term Debt Total | 439,011,000USD | 122,998,000USD | 124,377,000USD | 129,849,000USD | 139,698,000USD | 115,081,000USD | 5,031,000USD | — |
| Long Term Debt | 112,452,000USD | 113,632,000USD | 112,730,000USD | 97,240,000USD | 125,100,000USD | 107,983,000USD | — | — |
| Net Receivables | 29,117,000USD | 20,316,000USD | 25,182,000USD | 72,971,000USD | 32,166,000USD | 2,690,000USD | 2,840,000USD | 372,000USD |
| Inventory | 4,184,000USD | 18,387,000USD | 16,177,000USD | 12,073,000USD | 11,122,000USD | 6,499,000USD | 2,472,000USD | 1,204,000USD |
| Accounts Payable | 9,175,000USD | 18,029,000USD | 15,569,000USD | 12,351,000USD | 12,080,000USD | 5,279,000USD | 3,329,000USD | 6,750,000USD |
| Property Plant Equipment Net | 1,297,000USD | 13,429,000USD | 16,133,000USD | 10,260,000USD | 11,230,000USD | 4,758,000USD | 6,274,000USD | 1,540,000USD |
| Property Plant Equipment Gross | 2,678,000USD | 18,749,000USD | 20,408,000USD | 15,930,000USD | 11,230,000USD | 4,758,000USD | 6,274,000USD | 1,540,000USD |
| Accumulated Other Comprehensive Income | -517,000USD | -1,421,000USD | -93,000USD | 1,823,000USD | 102,829,000USD | 42,998,000USD | 5,542,000USD | 5,659,000USD |
| Common Stock Shares Outstanding | 127,067,540shares | 97,159,966shares | 81,712,166shares | 78,152,964shares | 76,748,204shares | 65,410,292shares | 66,872,230shares | 53,830,234shares |
| Non Current Assets Total | 16,815,000USD | 14,590,000USD | 18,491,000USD | 55,879,000USD | 92,790,000USD | 63,242,000USD | 15,076,000USD | 8,478,000USD |
| Non Current Liabilities Total | 438,821,000USD | 444,153,000USD | 435,361,000USD | 329,469,000USD | 377,949,000USD | 137,751,000USD | 6,583,000USD | 1,961,000USD |
| Non Current Liabilities Other | 2,810,000USD | 2,433,000USD | 8,879,000USD | 838,000USD | — | 221,000USD | — | — |
| Non Currrent Assets Other | 15,518,000USD | 1,161,000USD | 711,000USD | -13,458,000USD | 693,000USD | 397,000USD | 368,000USD | 264,000USD |
| Net Working Capital | 236,172,000USD | 226,921,000USD | 268,621,000USD | 347,058,000USD | 451,247,000USD | 410,014,000USD | 102,663,000USD | 119,726,000USD |
| Unclassified Current Liabilities | -3,000,000USD | — | — | -12,474,000USD | -6,575,000USD | -8,910,000USD | — | — |
| Unclassified Non Current Liabilities | 323,559,000USD | 328,088,000USD | 313,752,000USD | 205,110,000USD | 187,080,000USD | -70,964,000USD | 3,899,000USD | — |
| Unclassified Equity | 1,428,464,000USD | 1,275,247,000USD | 1,172,692,000USD | 1,158,423,000USD | 975,254,000USD | 974,738,000USD | 545,461,000USD | 451,867,000USD |
| Long Term Investments | — | 0USD | 1,647,000USD | 31,152,000USD | 41,236,000USD | 47,908,000USD | — | — |
| Other Assets | — | — | 1USD | 28,614,000USD | 27,373,000USD | 397,000USD | 368,000USD | 264,000USD |
| Intangible Assets | — | — | — | 14,360,000USD | 13,582,000USD | 10,179,000USD | 8,434,000USD | 6,674,000USD |
| Deferred Long Term Liab | — | — | — | 954,000USD | 631,000USD | — | — | — |
| Other Liab | — | — | — | 25,327,000USD | 65,138,000USD | 100,511,000USD | 2,684,000USD | 1,961,000USD |
| Net Tangible Assets | — | — | — | 75,321,000USD | 153,137,000USD | 325,326,000USD | 102,722,000USD | 119,569,000USD |
| Unclassified Non Current Assets | — | — | — | -28,507,000USD | -1,324,000USD | — | — | — |
| Current Deferred Revenue | — | — | — | — | 3,754,000USD | 149,000USD | 834,000USD | 1,765,000USD |
| Unclassified Current Assets | — | — | — | — | — | -6,498,999USD | -2,472,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Stock Based Compensation | 6,992,000USD |
| Other Non Cash Items | 322,000USD |
| Change To Account Receivables | 1,082,000USD |
| Change To Inventory | -3,276,000USD |
| Change To Liabilities | 4,030,000USD |
| Change In Working Capital | 62,000USD |
| Operating Cash Flow | -41,517,000USD |
| Capital Expenditures | -32,000USD |
| Investing Cash Flow | -32,000USD |
| Common Stock Issuance | 0USD |
| Net Common Stock Issuance | -985,000USD |
| Unclassified Financing Cash Flow | 303,000USD |
| Financing Cash Flow | -682,000USD |
| Effect Of Forex Changes On Cash | 0USD |
| Change In Cash | -42,231,000USD |
| End Cash Flow | 219,107,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -32,968,000USD | -6,409,000USD | -40,966,000USD | -56,646,000USD | -38,602,000USD | -30,727,000USD | -43,969,000USD | -36,544,000USD |
| Depreciation | 114,000USD | 113,000USD | 122,000USD | 1,490,000USD | 801,000USD | 236,000USD | 802,000USD | 838,000USD |
| Stock Based Compensation | 2,442,000USD | 6,127,000USD | 2,000,000USD | 2,061,999USD | 2,421,000USD | 2,779,000USD | 2,806,000USD | 1,988,000USD |
| Other Non Cash Items | 5,707,000USD | -19,085,516USD | 8,822,000USD | 7,441,001USD | 8,561,000USD | -488,000USD | 6,777,000USD | 5,692,000USD |
| Change To Account Receivables | -1,928,000USD | -6,398,144USD | 3,266,000USD | 5,577,000USD | -11,445,000USD | 3,713,000USD | -1,256,000USD | 319,000USD |
| Change To Inventory | 16,000USD | -868,237USD | -516,000USD | -706,000USD | -306,000USD | -2,798,000USD | -880,000USD | 518,000USD |
| Change In Working Capital | -5,005,000USD | -11,868,484USD | 392,000USD | 21,566,000USD | -29,515,000USD | 6,348,000USD | 8,541,000USD | -4,819,000USD |
| Total Cash From Operating Activities | -29,710,000USD | -31,123,000USD | -29,630,000USD | -24,087,000USD | -56,334,000USD | -21,852,000USD | -25,043,000USD | -32,845,000USD |
| Capital Expenditures | -32,000USD | -11,580USD | -2,186USD | -11,580USD | -264,000USD | -90,000USD | -216,000USD | -30,000USD |
| Free Cash Flow | -29,742,000USD | -31,134,580USD | -29,630,000USD | -24,087,000USD | -56,598,000USD | -21,942,000USD | -25,259,000USD | -32,875,000USD |
| Total Cashflows From Investing Activities | -32,000USD | 687,910USD | -2,185USD | -11,575USD | -264,000USD | -90,000USD | -216,000USD | -30,000USD |
| Total Cash From Financing Activities | -583,000USD | 58,208,554USD | -198,000USD | 93,783,000USD | 271,000USD | -1,120,000USD | -879,000USD | 98,697,000USD |
| Sale Purchase Of Stock | -20,000USD | — | — | -250,000USD | 0USD | -1,163,000USD | — | — |
| Change In Cash | -30,330,000USD | 26,600,000USD | -29,822,000USD | 69,859,000USD | -56,166,000USD | -23,405,000USD | -25,847,000USD | 65,834,000USD |
| Begin Period Cash Flow | 261,338,000USD | 234,738,000USD | 264,560,000USD | 194,701,000USD | 250,867,000USD | 274,272,000USD | 300,119,000USD | 234,285,000USD |
| End Period Cash Flow | 231,008,000USD | 261,338,000USD | 234,738,000USD | 264,560,000USD | 194,701,000USD | 250,867,000USD | 274,272,000USD | 300,119,000USD |
| Other Cashflows From Financing Activities | -768,000USD | -1,310,477USD | 281,000USD | 94,033,000USD | 271,000USD | 43,000USD | 346,000USD | 98,697,000USD |
| Issuance Of Capital Stock | — | 43,522,000USD | -479,000USD | — | — | 0USD | -1,225,000USD | — |
| Other Cashflows From Investing Activities | — | 699,485USD | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | 15,997,031USD | — | — | — | — | — | — |
| Investments | — | — | 0USD | 0USD | -264,000USD | -90,000USD | -216,000USD | -30,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -142,623,000USD | -157,846,000USD | -240,053,000USD | -157,128,000USD | -230,026,000USD | -246,290,000USD | -116,484,000USD | -123,096,000USD |
| Depreciation | 1,876,000USD | 3,276,000USD | 3,267,000USD | 5,741,000USD | 2,630,000USD | 2,188,000USD | 1,646,000USD | 740,000USD |
| Stock Based Compensation | 6,905,000USD | 6,568,000USD | 13,495,000USD | 50,636,000USD | 60,480,000USD | 37,585,000USD | 1,117,000USD | 469,000USD |
| Other Non Cash Items | 18,023,000USD | 20,341,000USD | 23,230,000USD | 11,475,000USD | -24,703,000USD | 25,099,000USD | -1,185,000USD | -891,000USD |
| Change To Account Receivables | -8,789,000USD | 4,771,000USD | 47,789,000USD | -42,753,000USD | -30,218,000USD | -30,218,000USD | 192,000USD | 895,000USD |
| Change To Inventory | -2,381,000USD | -3,728,000USD | -5,712,000USD | -9,651,000USD | -3,022,000USD | -3,022,000USD | -2,310,000USD | 1,584,000USD |
| Change In Working Capital | -25,355,000USD | 3,826,000USD | 44,271,000USD | -49,035,000USD | -15,710,000USD | 12,362,000USD | -7,883,000USD | 481,000USD |
| Total Cash From Operating Activities | -141,174,000USD | -123,835,000USD | -118,686,000USD | -138,311,000USD | -233,378,000USD | -168,729,000USD | -121,581,000USD | -121,362,000USD |
| Capital Expenditures | -264,000USD | -867,000USD | -3,216,000USD | -687,000USD | -6,376,000USD | -2,809,000USD | -2,148,000USD | -2,470,000USD |
| Free Cash Flow | -141,438,000USD | -124,702,000USD | -121,902,000USD | -138,998,000USD | -239,754,000USD | -171,538,000USD | -123,729,000USD | -123,832,000USD |
| Total Cashflows From Investing Activities | 395,000USD | -867,000USD | -3,216,000USD | -687,000USD | -6,673,000USD | -2,828,000USD | -2,248,000USD | -2,506,000USD |
| Total Cash From Financing Activities | 150,945,000USD | 97,054,000USD | 73,875,000USD | -897,000USD | 267,394,000USD | 494,966,000USD | 100,512,000USD | -24,000USD |
| Issuance Of Capital Stock | 86,282,000USD | 60,506,000USD | -62,000USD | 6,130,000USD | 188,945,000USD | 433,158,000USD | 41,000USD | — |
| Change In Cash | 10,471,000USD | -27,731,000USD | -47,843,000USD | -140,103,000USD | 27,349,000USD | 323,644,000USD | -23,256,000USD | -123,945,000USD |
| Begin Period Cash Flow | 250,867,000USD | 278,598,000USD | 326,441,000USD | 466,544,000USD | 439,195,000USD | 115,551,000USD | 138,807,000USD | 262,752,000USD |
| End Period Cash Flow | 261,338,000USD | 250,867,000USD | 278,598,000USD | 326,441,000USD | 466,544,000USD | 439,195,000USD | 115,551,000USD | 138,807,000USD |
| Other Cashflows From Financing Activities | -1,514,000USD | 36,548,000USD | 73,875,000USD | 3,125,000USD | 218,780,000USD | 54,000USD | 101,614,000USD | -24,000USD |
| Unclassified Financing Cash Flow | 66,177,000USD | — | — | 3,795,000USD | — | 433,158,000USD | — | 1,026,000USD |
| Investments | — | -867,000USD | -2,399,000USD | -2,508,000USD | -6,673,000USD | -2,828,000USD | -2,248,000USD | -2,506,000USD |
| Net Borrowings | — | — | 0USD | -6,502,000USD | 48,614,000USD | 61,754,000USD | -1,002,000USD | -1,002,000USD |
| Unclassified Operating Cash Flow | — | — | 37,104,000USD | — | -26,049,000USD | — | — | — |
| Unclassified Investing Cash Flow | — | — | 2,399,000USD | 2,718,000USD | 9,619,000USD | 2,828,000USD | 2,248,000USD | 2,506,000USD |
| Change To Liabilities | — | — | — | 310,000USD | 6,798,000USD | 1,921,000USD | -5,765,000USD | -1,998,000USD |
| Sale Purchase Of Stock | — | — | — | -1,315,000USD | 0USD | 0USD | -141,000USD | -24,000USD |
| Other Cashflows From Investing Activities | — | — | — | -210,000USD | -3,243,000USD | -19,000USD | -100,000USD | -36,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Geography | EMEA | 818,000 | USD | 0001628280-26-029819 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 20,033,000 | USD | 0001628280-26-029819 |
| Q1 2026Quarterly · 2026-03-31 | Product | License Revenues | 0 | USD | 0001628280-26-029819 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 20,033,000 | USD | 0001628280-26-029819 |
| Q1 2026Quarterly · 2026-03-31 | Product | Royalty Revenue | 818,000 | USD | 0001628280-26-029819 |
| Q4 2025Quarterly · 2025-12-31 | Geography | EMEA | 746,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | United States | 22,312,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | License Revenues | 0 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product | 22,312,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Royalty Revenue | 746,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | EMEA | 7,806,000 | USD | 0001628280-26-016491 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 73,551,000 | USD | 0001628280-26-016491 |
| FY 2025Yearly · 2025-12-31 | Product | License Revenues | 5,000,000 | USD | 0001628280-26-016491 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 73,551,000 | USD | 0001628280-26-016491 |
| FY 2025Yearly · 2025-12-31 | Product | Royalty Revenue | 2,806,000 | USD | 0001628280-26-016491 |
| Q3 2025Quarterly · 2025-09-30 | Geography | EMEA | 677,000 | USD | 0001628280-25-051095 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 15,750,000 | USD | 0001628280-25-051095 |
| Q3 2025Quarterly · 2025-09-30 | Product | License Revenues | 0 | USD | 0001628280-25-051095 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 15,750,000 | USD | 0001628280-25-051095 |
| Q3 2025Quarterly · 2025-09-30 | Product | Royalty Revenue | 677,000 | USD | 0001628280-25-051095 |
| Q2 2025Quarterly · 2025-06-30 | Geography | EMEA | 754,000 | USD | 0001771910-25-000008 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 18,085,000 | USD | 0001771910-25-000008 |
| Q2 2025Quarterly · 2025-06-30 | Product | License Revenues | 0 | USD | 0001771910-25-000008 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 18,085,000 | USD | 0001771910-25-000008 |
| Q2 2025Quarterly · 2025-06-30 | Product | Royalty Revenue | 754,000 | USD | 0001771910-25-000008 |
| Q1 2025Quarterly · 2025-03-31 | Geography | EMEA | 5,629,000 | USD | 0001628280-26-029819 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 17,404,000 | USD | 0001628280-26-029819 |
| Q1 2025Quarterly · 2025-03-31 | Product | License Revenues | 5,000,000 | USD | 0001628280-26-029819 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 17,404,000 | USD | 0001628280-26-029819 |
| Q1 2025Quarterly · 2025-03-31 | Product | Royalty Revenue | 629,000 | USD | 0001628280-26-029819 |
| Q4 2024Quarterly · 2024-12-31 | Geography | EMEA | 524,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 16,386,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | License Revenues | 0 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product | 16,386,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Royalty Revenue | 524,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | EMEA | 1,557,000 | USD | 0001628280-26-016491 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 69,280,000 | USD | 0001628280-26-016491 |
| FY 2024Yearly · 2024-12-31 | Product | License Revenues | 0 | USD | 0001628280-26-016491 |
| FY 2024Yearly · 2024-12-31 | Product | Other | 1,557,000 | USD | 0001628280-26-016491 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 69,280,000 | USD | 0001628280-26-016491 |
| Q3 2024Quarterly · 2024-09-30 | Geography | EMEA | 448,000 | USD | 0001628280-25-051095 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 18,016,000 | USD | 0001628280-25-051095 |
| Q3 2024Quarterly · 2024-09-30 | Product | License Revenues | 0 | USD | 0001628280-25-051095 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 18,016,000 | USD | 0001628280-25-051095 |
| Q3 2024Quarterly · 2024-09-30 | Product | Royalty Revenue | 448,000 | USD | 0001628280-25-051095 |
| Q2 2024Quarterly · 2024-06-30 | Geography | EMEA | 380,000 | USD | 0001771910-25-000008 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United States | 17,030,000 | USD | 0001771910-25-000008 |
| Q2 2024Quarterly · 2024-06-30 | Product | License Revenues | 0 | USD | 0001771910-25-000008 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product | 17,030,000 | USD | 0001771910-25-000008 |
| Q2 2024Quarterly · 2024-06-30 | Product | Royalty Revenue | 380,000 | USD | 0001771910-25-000008 |
| FY 2023Yearly · 2023-12-31 | Geography | EMEA | 498,000 | USD | 0001628280-24-010843 |
| FY 2023Yearly · 2023-12-31 | Geography | Japan | 0 | USD | 0001628280-24-010843 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 69,060,000 | USD | 0001628280-24-010843 |
| FY 2023Yearly · 2023-12-31 | Product | License Revenues | 0 | USD | 0001628280-24-010843 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 69,060,000 | USD | 0001628280-24-010843 |
| FY 2023Yearly · 2023-12-31 | Product | Royalty Revenue | 498,000 | USD | 0001628280-24-010843 |
| FY 2022Yearly · 2022-12-31 | Geography | EMEA | 105,000,000 | USD | 0001628280-24-010843 |
| FY 2022Yearly · 2022-12-31 | Geography | Japan | 30,000,000 | USD | 0001628280-24-010843 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 74,908,000 | USD | 0001628280-24-010843 |
| FY 2022Yearly · 2022-12-31 | Product | License Revenues | 135,000,000 | USD | 0001628280-24-010843 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 74,908,000 | USD | 0001628280-24-010843 |
| FY 2022Yearly · 2022-12-31 | Product | Royalty Revenue | 0 | USD | 0001628280-24-010843 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.